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Summary
Perinatal care of pregnant women at high risk for preterm
delivery and of preterm infants born at the limit of viability
(22–26 completed weeks of gestation) requires a mul-
tidisciplinary approach by an experienced perinatal team.
Limited precision in the determination of both gestational
age and foetal weight, as well as biological variability may
significantly affect the course of action chosen in individu-
al cases.
The decisions that must be taken with the pregnant women
and on behalf of the preterm infant in this context are
complex and have far-reaching consequences. When coun-
selling pregnant women and their partners, neonatologists
and obstetricians should provide them with comprehensive
information in a sensitive and supportive way to build a
basis of trust. The decisions are developed in a continuing
dialogue between all parties involved (physicians, mid-
wives, nursing staff and parents) with the principal aim to
find solutions that are in the infant’s and pregnant woman's
best interest.
Knowledge of current gestational age-specific mortality
and morbidity rates and how they are modified by pren-
atally known prognostic factors (estimated foetal weight,
sex, exposure or nonexposure to antenatal corticosteroids,
single or multiple births) as well as the application of ac-
cepted ethical principles form the basis for responsible
decision-making. Communication between all parties in-
volved plays a central role.
The members of the interdisciplinary working group sug-
gest that the care of preterm infants with a gestational age
between 22 0/7 and 23 6/7 weeks should generally be lim-
ited to palliative care. Obstetric interventions for foetal in-
dications such as Caesarean section delivery are usually not
indicated. In selected cases, for example, after 23 weeks of
pregnancy have been completed and several of the above
mentioned prenatally known prognostic factors are favour-
able or well informed parents insist on the initiation of life-
sustaining therapies, active obstetric interventions for foet-
al indications and provisional intensive care of the neonate
may be reasonable.
In preterm infants with a gestational age between 24 0/7
and 24 6/7 weeks, it can be difficult to determine whether
the burden of obstetric interventions and neonatal intensive
care is justified given the limited chances of success of
such a therapy. In such cases, the individual constellation
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of prenatally known factors which impact on prognosis can
be helpful in the decision making process with the parents.
In preterm infants with a gestational age between 25 0/7
and 25 6/7 weeks, foetal surveillance, obstetric interven-
tions for foetal indications and neonatal intensive care
measures are generally indicated. However, if several pren-
atally known prognostic factors are unfavourable and the
parents agree, primary non-intervention and neonatal palli-
ative care can be considered.
All pregnant women with threatening preterm delivery or
premature rupture of membranes at the limit of viability
must be transferred to a perinatal centre with a level III
neonatal intensive care unit no later than 23 0/7 weeks of
gestation, unless emergency delivery is indicated. An ex-
perienced neonatology team should be involved in all de-
liveries that take place after 23 0/7 weeks of gestation to
help to decide together with the parents if the initiation of
intensive care measures appears to be appropriate or if pref-
erence should be given to palliative care (i.e., primary non-
intervention). In doubtful situations, it can be reasonable
to initiate intensive care and to admit the preterm infant
to a neonatal intensive care unit (i.e., provisional intensive
care). The infant’s clinical evolution and additional discus-
sions with the parents will help to clarify whether the life-
sustaining therapies should be continued or withdrawn.
Life support is continued as long as there is reasonable
hope for survival and the infant’s burden of intensive care
is acceptable. If, on the other hand, the health care team
and the parents have to recognise that in the light of a very
poor prognosis the burden of the currently used therapies
has become disproportionate, intensive care measures are
no longer justified and other aspects of care (e.g., relief of
pain and suffering) are the new priorities (i.e., redirection
of care). If a decision is made to withhold or withdraw life-
sustaining therapies, the health care team should focus on
comfort care for the dying infant and support for the par-
ents.
Key words: limit of viability; ethical decision-making;
provisional intensive care; redirection of care
Introduction
These recommendations refer to the perinatal care of wo-
men at high risk of preterm delivery and preterm infants
at the limit of viability (gestational age between 22 and 26
completed weeks). They have been written for physicians,
midwives, nurses and other professionals who are involved
in the care of this high risk population.
The first recommendations for the care of infants born
at the limit of viability were published in Switzerland in
2002 [1]. At the time, recommendations of European [2,
3] and Canadian [4] societies were reviewed, and together
with the relevant ethical guidelines of the Swiss Academy
of Medical Sciences [5, 6] served as the basis for these
recommendations. The fact that revised recommendations
from North America and Europe [7–11] as well as new
recommendations from additional countries [12–17] have
since been published and new mortality and morbidity data
[18–22], including results from Switzerland [23, 24], have
become available, has prompted the Swiss Society of
Neonatology to recommend the revision of the Swiss re-
commendations.
National recommendations are necessary because ethical
decision making is not only based on widely accepted eth-
ical principles but also strongly influenced by social, eco-
nomic and legal considerations. High quality outcome re-
search is important and results from such studies vary con-
siderably between different countries [18–24]. Therefore,
adoption of similar guidelines from other countries would
be unlikely to gain wide acceptance in Switzerland. Such
acceptance, however, is important to minimize potentially
problematic centre-to-centre variability in the care of wo-
men at high risk of preterm delivery and their infants.
The new recommendations were elaborated by a group
of experienced specialists. The current literature was re-
viewed and representatives of each specialty contributed to
the respective chapters of the new recommendations. The
changes were discussed in detail during five meetings in
2009 and 2010. The final version of the new recommenda-
tions was approved by all members of the working group as
well as the Swiss Society of Gynaecology and Obstetrics,
the Swiss Academy of Fetomaternal Medicine, the Swiss
Association of Midwives, the Swiss Society of Paediatrics,
the Swiss Society of Neonatology and the Swiss Society of
Developmental Paediatrics. As in 2002, the Central Ethic-
al Committee of the Swiss Academy of Medical Sciences
supports the new recommendations.
Compared with the 2002 version, the new recommenda-
tions include specific information on obstetrical interven-
tions, in particular on foetal lung maturation and the role of
Caesarean section delivery. Up-to-date information on cur-
rent mortality and morbidity rates is provided. In the pre-
vious version of the recommendations, gestational age was
the main determinant for the suggested management al-
gorithm. The new recommendations highlight the fact that
apart from stratification by gestational age, factors signi-
ficantly affecting prognosis must be taken into account.
The grey zone is more narrowly defined but its borders are
not absolute allowing for an individualised approach in the
perinatal care at the limit of viability. The importance of
communication skills is again emphasised and the role of
the parents in the decision making process is explained in
more detail.
Background
Calculation of gestational age and birth weight and
biological variability
The International Classification of Disease (10th revision)
defines the gestational age as the postmenstrual age in
weeks and days. The time period between 25 weeks and
0 days (25 0/7 weeks) and 25 weeks and 6 days (25 6/7
weeks), for example, corresponds to 175–181 days and is
termed 25 completed weeks of gestation; the foetus is in
the 26th week of gestation.
The calculation of the gestational age is generally based
on ultrasound measurements of the crown-rump length in
early pregnancy (10 0/7 to 13 6/7 weeks of gestation) and/
or the history of the first day of the last menstrual peri-
od. It is important to realise that the precision of gestation-
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al age determination by early ultrasound is ± 4 days [25,
26], whereas a much wider range of – 6 to + 14 days must
be accepted when the history of the last menstrual period
is used. When there is no early ultrasound estimate of the
gestational age, clinical assessment after delivery may lead
to a revision of the estimated gestational age. Similarly, ul-
trasonographic estimations of foetal weight can vary from
the actual weight by ± 15% and thus significantly affect
prognosis. The parents need to be informed about possible
inaccuracies of these measurements to avoid unnecessary
confusion in such a situation.
Because there can be variability in maturity at any given
gestational age, preterm infants of identical gestational age
may exhibit significantly different biological maturity
which in turn may influence their therapeutic requirements
and even affect individual mortality and morbidity risks. It
has been shown by different researchers that some factors
that can be determined prenatally have an impact on pro-
gnosis [20, 27].
Current mortality and morbidity rates
Knowledge of reliable mortality and morbidity rates is of
utmost importance for sound perinatal decision making.
Gestational age is the most important prognostic factor.
However, sex, estimated foetal weight, single or multiple
birth and exposure or non-exposure to antenatal corticos-
teroids are additional relevant factors that affect mortality
and morbidity risks of preterm infants with a gestational
age <26 completed weeks (table 1). Apart from published
national and international statistics, local outcome data of
preterm infants at the limit of viability are essential.
Mortality
With the continuing progress of neonatal intensive care, the
limit of viability has continued to shift towards younger
gestational ages. For example, survival after only 22 com-
pleted weeks of gestation has been described [3, 28]. A
comparison between published international figures
[18–22] and results of the Swiss Minimal Neonatal Data
Set (MNDS) [23, 24] shows that there are considerable
differences in mortality rates between different countries.
In Switzerland, mortality rates of preterm infants born at
the limit of viability vary significantly between different
centres that care for such patients [23]. At the same time,
mortality rates continue to decrease internationally and
have reached 33–49% for preterm infants with a gestational
age between 24 0/7 and 24 6/7 weeks [18–22]. On the other
hand, mortality rates for infants born in the 24th week of
gestation (i.e., with a gestational age between 23 0/7 and 23
6/7 weeks) remain above 60% at most centres [18, 20–22]
(table 2).
Morbidity
The selection of suitable follow-up studies to determine the
prevalence of neurosensory deficits in surviving extremely
preterm infants is hampered by study design heterogeneity,
inadequate size of study populations and variability in age
at follow-up. Therefore, only the four largest multicentre
studies that were published in the last five years which de-
scribed the outcome of large cohorts were analysed [20, 21,
29, 30]. In addition, only rates of severe impairment (PDI
and/or MDI <70, moderate or severe cerebral palsy, blind-
ness, deafness) and profound impairment (PDI and/or MDI
<50 or IQ <55, adult assistance is required to move, blind-
ness, deafness) were evaluated since only these are poten-
tially relevant in ethical life and death decision making.
Among surviving preterm infants with a gestational age
≥25 0/7 weeks, rates of severe and/or profound impairment
are generally less than 50%. At lower gestational ages,
however, these rates increase markedly but vary signific-
antly between different studies for infants of the same gest-
ational age (table 3).
Ethical considerations
High mortality and morbidity rates of extremely preterm
infants as a group (tables 2 and 3), on the one hand, and
prognostic uncertainty in individual cases, on the other
hand, render ethical decision making difficult. The limit
beyond which health care professionals feel that intensive
care measures are no longer justified is influenced by their
cultural and personal background. There is, however, gen-
eral consensus regarding the importance of the relevant
Table 1: Prognostic impact of prenatally known factors (sex, estimated foetal weight, single or multiple birth and exposure or non-exposure to antenatal corticosteroids) on
gestational age-specific outcomes [20].
Gestational age (weeks) Sex Birth
weight
Singleton ANC1 Survival
rate2
Survival without profound
impairment2,3
Survival without severe
impairment2,4
24 0/7 – 24 6/7 m 600 g no no 27% 15% 7%
24 0/7 – 24 6/7 f 600 g no no 36% 24% 14%
24 0/7 – 24 6/7 f 800 g no no 63% 48% 34%
24 0/7 – 24 6/7 f 800 g yes no 67% 53% 39%
24 0/7 – 24 6/7 f 800 g yes yes 82% 71% 57%
1 antenatal corticosteroids to accelerate foetal lung maturation
2 as percentage of all live born infants (n = 4446)
3 profound impairment Bayley score <50 (untestable)
• level 5 for gross motor function (adult assistance required to move)
4 severe impairment at the age of 18-22 months:
• PDI and/or MDI ≤70
• moderate or severe CP
• bilateral blindness
• bilateral hearing loss requiring amplification
These estimates are based on standardised assessments of outcomes at 18 to 22 months of infants born at Neonatal Research Network (NRN) centers between 1998 and
2003; infants were 22 to 25 weeks, between 401 and 1,000 grams at birth. Infants not born at a Network center and Infants with a major congenital anomaly were
excluded.
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ethical principles proposed by Beauchamp and Childress
[31]. It is widely accepted that beneficence, non-malefi-
cence, autonomy and justice must be considered, but sev-
eral conflicts arise when these principles are applied to the
situation of preterm infants at the limit of viability [32].
Physician's duty to preserve life
A first conflict arises from the question of how the physi-
cian’s duty to preserve life could be modified by thoughts
about the achievable quality of life. If it is not permissible
to take the quality of life into account and human life
must be supported with all available means, there is a risk
of excessive therapy. On the other hand, to only accept
life-prolonging therapies if a certain quality of life can be
guaranteed to the preterm infant must be regarded as dis-
crimination toward the disabled. A possible compromise
between these two extreme positions might be to always
ask the question if the suffering imposed on the patient by
the various interventions can be ethically justified when
confronted with a very unfavourable prognosis.
The decision to withhold or withdraw life-sustaining ther-
apies is motivated by the desire to protect the preterm in-
fant from undue suffering and not by the wish to prevent
survival with handicaps.
Decision making when there is prognostic uncertainty
Mortality and morbidity rates of preterm infants show a
strong correlation with gestational age leading to world-
wide agreement that there is a limit below which life-
sustaining therapies will not be successful and, therefore,
should not be used. Similarly, it is also generally accepted
that there is a gestational age limit above which non-initi-
ation of life-sustaining intensive care measures could not
be ethically justified. Since improvement of prognosis is
not sudden but gradual, there is a grey zone between those
two limits which is characterised by uncertainty. Conse-
quently, there is no consensus if the burden of life-sustain-
ing therapies in these borderline viable infants is acceptable
or not.
Within this grey zone, an additional line can be drawn in-
dicating the limit where the judgement of the reasonable-
ness of the burden of intensive care changes from negative
to positive. With this concept in mind, four zones that re-
quire different courses of action can be differentiated (table
4).
The precise designation of the borders of these zones will
be influenced by the best available mortality and morbidity
data observed among patients of a particular gestational
age, both nationally and locally, but will also be affected
by individual values. How can the chance of survival with
a good quality of life be balanced against the risk of dying
or surviving with a severely restricted quality of life after
having experienced the full burden of intensive care? A na-
tional consensus regarding the designation of these borders
Table 2: Comparison of mortality rates reported from Switzerland, the United States, Sweden and Australia.
Mortality rates1
Gestational age
(weeks)
Switzerland
(2000–2004)2
[23]
n = 516
Switzerland
(2005–2009)2
[unpublished]
n = 562
USA – NICHD
(1998–2003)
[20]
n = 4446
USA – NICHD
(2003–2007)
[22]
n = 4160
USA – VON
(1998–2003)
[21]
n = 4477
Sweden
(2004–2007)
[19]
n = 707
Australia (2005)
[18]
n = 157
22 0/7 – 22 6/7 100%
(NA)
100%
(NA)
95% 94% 96% 90% 95%
23 0/7 – 23 6/7 89%
(80–100)
96%
(73–100)
74% 74% 62% 48% 78%
24 0/7 – 24 6/7 70%
(47–100)
69%
(27–100)
44% 45% 37% 33% 49%
25 0/7 – 25 6/7 49%
(26–62)
39%
(11–62)
25% 28% 24% 19% 33%
1 as percentage of all live born infants
2 figures in parenthesis indicate ranges between the centres
Table 3: Mortality rates and rates of permanent neurosensory impairment among extremely preterm infants.
Gestational age
(weeks)
Mortality rates1 Survival with profound
impairment2,3
Survival with severe
impairment2,4
Survival without severe or
profound impairment 2–4
22 0/7 – 22 6/7 94–95%
[20, 21]
60%
[20]
73–80%
[20, 21]
20–27%
[20, 21]
23 0/7 – 23 6/7 62–74%
[20, 21]
20–38%
[20, 28, 29]
27–52%
[20, 21, 28]
10–53%
[20, 21, 28]
24 0/7 – 24 6/7 37–44%
[20, 21]
23–40%
[20, 28, 29]
22–44%
[20, 21, 28]
16–55%
[20, 21, 28]
25 0/7 – 25 6/7 24–25%
[20, 21]
17–25%
[20, 28, 29]
22–27%
[20, 21, 28]
48–61%
[20, 21, 28]
1 as percentage of all live born infants
2 as percentage of survivors
3 profound impairment Bayley score <50 (untestable)
• level 5 for gross motor function (adult assistance required to move)
4 severe impairment at the age of 18–22 months:
• PDI and/or MDI ≤70
• moderate or severe CP
• bilateral blindness
• bilateral hearing loss requiring amplification
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is important to guarantee a just distribution of health care
resources and to avoid a problematic medical tourism.
These gestational age limits cannot be used schematically
for decision making in individual patients. Factors that can
be determined prenatally and are known to impact on pro-
gnosis must be adequately considered since they can shift
the patient's individual prognosis from one zone to another
(table 1). Finally, individual values of the members of the
health care team and particularly of the parents will also
play a role.
Decision maker
Since the preterm infant whose life is directly affected by
the treatment decisions cannot communicate his/her prefer-
ences, decisions must be made by proxy. Basically, this sur-
rogate role could potentially be played by the health care
team, the parents of the infant or by a societal body, such as
an ethics committee or a court of law.
Ideally, such decisions should not be made by a single party
at a particular point in time but should rather be developed
in an ongoing dialogue between all parties involved (phys-
icians, nursing staff, parents) (i.e., shared decision mak-
ing). In a first step, the health care team must determine
which therapeutic recommendations will result, based on
the above defined criteria. If these fall within the grey zone,
discussions with the parents will help to define which de-
cisions correspond best with the values of the parents.
Parental preferences are particularly important when the
health care team is confronted with considerable ethical
dilemmas (table 4). In general, parental authority should
be respected when an intervention has to be classified as
not (zone B) or conditionally (zone C) recommended.
However, parental authority is not unlimited: they cannot
insist on an unreasonable intervention (zone A), neither can
they reject a therapy that their infant very likely would be-
nefit from (zone D). It is important to realise that depend-
ing on their cultural background, parental wishes and abil-
ities to participate in the decision making process can differ
considerably.
Since there is no possibility to prove the moral correctness
of decisions taken when faced with an ethical dilemma,
successful decision making will be defined by how the
parties involved (parents, health care team) judge the pro-
cess and how they cope with the consequences of the de-
cision in the long run. Experience has shown that the fol-
lowing aspects characterise decision making that will least
likely result in persistent accusations and feelings of guilt:
open and careful information of the parents adapted to their
needs, sound and credible justification of the decision as
well as honest and empathic communication and support
[33].
Health care resources
The question could be raised whether a considerable pro-
portion of available health care resources should be alloc-
ated to the treatment of barely viable preterm infants with a
very unfavourable prognosis, if at the same time resources
are lacking in other areas of the health care system.
If rationing of potentially helpful therapies is unavoidable,
it should be done by rejecting therapies with marginal ef-
fectiveness, limited usefulness or a very poor cost-benefit
ratio for all patients rather than by excluding certain cat-
egories of patients (e.g., preterm infants at the limit of vi-
ability) from a particular therapy. Such decisions must al-
ways be made on a societal level; economic considerations
should not interfere with ethical decision making in an in-
dividual case.
Communication
Prenatal ethical decision making regarding maternal and
foetal interventions at the limit of viability is rationally and
emotionally challenging both for parents and physicians.
To communicate complex issues in an appropriate way and
adapted to the parent's level of understanding requires com-
petence and experience. Therefore, these discussions must
be led by experienced and appropriately trained obstetri-
cians and neonatologists. The goal of these conversations is
to establish a trusting relationship between the parents and
the health care team. The parents should be provided with
adequate information so that they can actively participate
in the decision making regarding pre- and postnatal mater-
nal and infant care.
Communication among members of the perinatal team
The perinatal care of a foetus or a preterm infant at the limit
of viability must follow a multidisciplinary approach and
requires close cooperation among obstetricians, neonato-
logists, midwives, nurses and other involved parties. Fre-
quently, decisions have to be made within a short period
of time. It is therefore necessary that the members of the
perinatal team have previously discussed and agreed upon
a standard approach in such situations.
Communication with the parents
Obstetricians and neonatologists should inform both par-
ents about the situation of the unborn child and his/her
likely short- and long-term prognosis. This information
should be precise, comprehensive and unbiased and should
be presented using appropriate expressions and understand-
able language. It has been shown that the way messages
Table 4: Stratification of decision making at the limit of viability: zones B and C designate the grey zone.
Zone Intensive care Burden Comment
A not indicated not acceptable parents cannot insist on an unreasonable
intervention
B not recommended, but acceptable in individual
cases
likely not to be acceptable parental authority should be respected
C conditionally recommended, but non-initiation
acceptable in individual cases
likely to be acceptable parental authority should be respected
D recommended acceptable parents cannot reject interventions that is in the
infant's best interest
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are relayed significantly influences the parent's perception
of their child’s condition and their treatment decisions [34].
Therefore, information should not only focus on mortality
and handicap rates but also mention chances for intact
survival to avoid inappropriately influencing the decision
making. Great care must be taken that the parent's cultural
background and their ability to understand complex issues
are adequately taken into account. In doubtful situations,
the services of professional translators or cultural medi-
ators should be used liberally. Parental expectations and
hopes should be carefully explored and compared to the
published prognostic data. Frequently, parents have unreal-
istic expectations not only of what is medically feasible but
also of the prognosis of their child, independent of which
therapeutic options are recommended. It is important to
realise that outcome data describe probabilities of a cohort
that can easily be misinterpreted by the parents. Therefore,
it is crucial that parents understand that there is always
some degree of uncertainty regarding the prognosis of an
individual child.
Following detailed information, most parents are grateful
when physicians suggest a treatment plan. Physicians are
obliged to support parents in their role as their child’s
proxy. Parents should be given sufficient time to ask ques-
tions, to address unclear issues of the conversation or to
weigh risks and benefits of the proposed therapeutic
strategies. Further conversations among family members or
support by members of the hospital clergy can be helpful.
Parents should also be informed that because of the impre-
cision of prenatal estimates of gestational age and foetal
weight it may occasionally be necessary to revise prenatal
agreements immediately after birth.
Occasionally, there is a need for several conversations, par-
ticularly when pregnancy continues and the infant's pro-
gnosis changes. Because continuity and emotional relations
are important to parents, additional discussions should be
lead by the same physicians. Written documentation of the
contents of all conversations and agreements made regard-
ing the care of the mother and her infant should readily be
available to all involved teams.
Parents should be informed that even if no resuscitative ef-
forts will be made, the infant will likely be born alive and
possibly live for several hours. If necessary, the infant will
receive analgesics to relieve any suffering (palliative care)
and will remain with the parents who will be supported by
the health care team. This will also apply if resuscitative ef-
forts are not successful.
Perinatal care at the limit of viability
between 22 and 26 completed weeks
of gestation
Prior to delivery
When foetal or maternal risk factors that may lead to the
delivery of an infant at the limit of viability are recognised,
obstetricians and neonatologists should discuss with the
parents the possibilities and limitations of the care of ex-
tremely preterm infants. Pregnant women at risk of preterm
delivery should be informed about the advantages of early
intrauterine transfer to a perinatal centre.
In utero transfer
Criteria for timely transfer of mothers experiencing
threatened preterm delivery must be defined clearly and
should be evaluated on a regular basis. Transfer of mothers
at risk to a perinatal centre should occur no later than at
23 0/7 weeks and possibly earlier if additional complica-
tions are present (e.g., premature rupture of membranes).
Although no intensive care measures would be initiated at
this age should delivery occur, transfer of the pregnant wo-
men allows for detailed counselling and preparation of the
parents. Parents should be informed about the referral in
such a way that their expectations are appropriate and re-
main realistic regarding their individual situation. In partic-
ular, parents must be told that the prognosis regarding mor-
tality and morbidity of infants born at the limit of viability
Figure 1
Impact of positive risk factors on shared decision making with the
parents in preterm infants with a gestational age between 23 0/7
and 23 6/7 weeks.
Figure 2
Impact of positive or negative risk factors on shared decision
making with the parents in preterm infants with a gestational age
between 24 0/7 and 24 6/7 SSW.
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is better when the transfer to a level III perinatal centre oc-
curs prior to delivery.
Obstetrical interventions (table 5)
Antenatal corticosteroids to accelerate foetal lung
maturation
In the presence of threatened preterm delivery, foetal lung
maturation should be accelerated as early as 24 0/7 weeks
of gestation with a single course of 2 doses of beta-
methasone 12 mg i.m. 24 hours apart [33–38]. In certain
situations, acceleration of foetal lung maturation can be
started a few days earlier, but not before 23 0/7 weeks [39].
As an exception, a second course can be administered if
the first two doses of betamethasone have been given very
early and the risk of preterm delivery has again increased
[40].
Delivery, delivery mode and placental period
After 24 0/7 weeks of gestation, active interventions for
foetal indications should be considered after completion of
the acceleration of foetal lung maturation; in special situ-
ations, particularly at the explicit wish of the fully informed
parents, it may also be considered prior to 24 0/7 weeks of
gestation, but not before 23 0/7 weeks of gestation.
Guidance regarding the impact of the mode of delivery,
particularly Caesarean section, on the prognosis of preterm
infants at the limit of viability can only be obtained from
retrospective studies and international recommendations
from experts [41–44]. In general, a Caesarean section
should not be performed routinely because of the gesta-
tional age alone, since rates of neurosensory impairment
have not decreased despite increasing rates of Caesarean
sections [45]. If the infant is in cephalic position, intra-
Figure 3
Impact of negative risk factors on shared decision making with the
parents in preterm infants with a gestational age between 25 0/7
and 25 6/7 SSW.
partum surveillance is possible and there are no maternal
and/or foetal risk factors, a Caesarean section does not of-
fer any benefit [46]. Caesarean section may reduce perinat-
al mortality of preterm infants with a gestational age <25
0/7 weeks, in multiples, in infants in breech presentation
and in growth restricted preterm infants with a gestational
age between 26 and 30 weeks [47–49]. The foetus should
be monitored with intrapartum cardiotocography (adapted
to the gestational age) in order to be able to intervene when
foetal well-being is threatened.
Different surgical techniques (classical vertical uterotomy
versus transverse uterotomy) have a significant influence
on postpartal morbidity, the risk of preterm delivery and
uterine rupture in subsequent pregnancies [50].
The delivery of a preterm infant at the limit of viability
should be optimised by additional obstetrical interventions.
It has been shown that delayed cord clamping and cord
milking is associated with improved haemodynamic stabil-
ity, a decreased blood transfusion requirement and a lower
incidence of intraventricular haemorrhages in preterm in-
fants with a gestational age of less than 34 0/7 weeks [51].
After delivery
Initial resuscitation in the delivery room (table 6)
Since the decisions whether intensive care measures should
be initiated in the delivery room are very complex and dif-
ficult with far reaching consequences, the birth of a pre-
term infant at the limit of viability should be regarded as
an emergency that requires the presence of experienced ob-
stetricians and neonatologists.
The individual interventions will be influenced by prenat-
ally known and prognostically relevant factors (gestation-
al age, estimated foetal weight, sex, exposure or non-ex-
posure to antenatal corticosteroids, single or multiple birth)
(table 1), and – particularly in the grey zone – by parental
preferences. It has been demonstrated that the clinical con-
dition of the infant after birth and the response to resus-
citative measures are not reliable prognostic factors [52].
Nevertheless, these factors influence the way the parents
and the health care team members experience individual
situations and cannot be completely ignored.
Resuscitation when gestational age is uncertain
An experienced neonatology team should attend all deliv-
eries that occur at an estimated gestational age ≥23 com-
pleted weeks in order to decide whether the initiation of in-
tensive care measures appears to be justified or preference
should be given to palliative care measures (i.e., primary
non-intervention).
In doubtful cases, it is appropriate to initiate intensive care
measures and to admit the preterm infant to the neonatal in-
tensive care unit (i.e., to provide provisional intensive care)
until the clinical course and further discussions with the
parents help clarify whether the treatment should be con-
tinued or redirected.
Resuscitation when gestational age is certain
Based on the prenatal discussions with the parents, an ex-
perienced neonatology team must decide whether it is reas-
onable to initiate intensive care measures. Provisional in-
tensive care often enables the health care team to more
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fully evaluate the infant’s condition at a later time point;
this possibly provides better arguments for continuation or
withdrawal of intensive care measures.
The care of preterm infants with a gestational age <24
0/7 weeks should generally be limited to palliative meas-
ures. If a preterm infant appears significantly more mature
after delivery or if previously well-informed parents insist,
provisional intensive care can be started until the clinical
course helps to decide if intensive care measures should be
continued. Provisional intensive care can also be reason-
able in selected cases when several of the above mentioned
prenatally known factors positively influence the prognosis
(fig. 1).
In preterm infants with a gestational age between 24 0/7
– 24 6/7 weeks, it can be difficult to determine whether
the burden of intensive care is justified given the limited
chances of success of such a therapy. In such cases, the in-
dividual constellation of additional prenatally known pro-
gnostic factors can be helpful in the decision making pro-
cess with the parents (fig. 2).
In preterm infants with a gestational age ≥25 0/7 weeks, in-
tensive care measures are generally indicated. However, if
several prenatally known factors are unfavourable and the
parents agree, primary non-intervention and palliative care
can be considered (fig. 3).
Decision making in the neonatal intensive care unit
Provisional intensive care
Intensive care interventions that are initiated in the delivery
room and continued in the neonatal intensive care unit
are based on the therapeutic goal. The primary aim is to
help the infant survive and to minimise potential permanent
impairments.
If a decision is made to provide provisional intensive care
to a preterm infant at the limit of viability, the treatment
should be optimised to avoid secondary injuries at all cost.
To refrain from applying intensive care interventions that
are used in more mature preterm infants is not justified.
As long as there is reasonable hope that the primary goal
can be reached and the burden of the interventions used ap-
pears justified, the necessary therapies are continued. The
parents should be informed regularly about the infant’s
clinical course.
Redirection of care
If the health care team and the parents have to recognise
that the primary goal can no longer be reached, intensive
care measures are no longer justified and other aspects of
care (e.g., the use of opioids to diminish pain and suffering)
become the new priorities (i.e., redirection of care to com-
fort measures). Decisions regarding withdrawal of intens-
ive care measures should be carefully documented in the
patient record. These notes should include a detailed de-
scription of the considerations and reasons that have led to
a particular decision.
Palliative care
Whenever life sustaining therapies are withheld (either
primarily or secondarily), everything should be done to al-
low the infant to die peacefully and with dignity (i.e., com-
fort care). At the same time, the parents should be given the
opportunity of close contact with their dying child to bid
farewell. If necessary for adequate pain control, opiates can
be used at doses that might have a life-shortening effect [5].
In contrast, the use of drugs with the primary intention to
end a preterm infant’s life is against the law and not con-
sistent with the ethical position described above.
Recommendations for quality
assessment and improvement
Quality assessment and improvement plays an important
role in the care of preterm infants born at the limit of viabil-
Table 5: Algorithm and classification of obstetrical interventions.
Gestational age (weeks) In utero transfer to a perinatal centre Antenatal corticosteroids Caesarean section
<22 0/7 not indicated not indicated only for maternal indications
22 0/7 – 22 6/7 possibly indicated not indicated only for maternal indications
23 0/7 – 23 6/7 indicated possibly indicated rarely for foetal indications
24 0/7 – 24 6/7 indicated indicated to be considered for foetal indications
25 0/7 – 25 6/7 indicated indicated to be considered for foetal indications
Note: gestational age stratification of obstetrical and neonatal interventions is only a first step in the decision making process. Prenatally known prognostic factors (sex,
estimated foetal weight, single or multiple birth and exposure or non-exposure to antenatal corticosteroids) can have a significant impact on mortality and morbidity rates
(see table 1). Inborns have a better prognosis than outborns. The clinical condition of the infant immediately after birth and the response to resuscitative measures are not
reliable prognostic factors.
Table 6: Algorithm and classification of neonatal interventions.
Gestational age (weeks) Neonatal care Classification of intensive care measures
<22 0/7 comfort care not indicated (burden not acceptable)
22 0/7 – 22 6/7 comfort care not indicated (burden not acceptable)
23 0/7 – 23 6/7 generally comfort care not recommended, but acceptable in individual cases (burden likely not to be
acceptable)
24 0/7 – 24 6/7 generally provisional intensive care conditionally recommended, but non-institution acceptable in individual cases
(burden likely to be acceptable)
25 0/7 – 25 6/7 provisional intensive care recommended (burden acceptable)
Note: gestational age stratification of obstetrical and neonatal interventions is only a first step in the decision making process. Prenatally known prognostic factors (sex,
estimated foetal weight, single or multiple birth and exposure or non-exposure to antenatal corticosteroids) can have a significant impact on mortality and morbidity rates
(see table 1). Inborns have a better prognosis than outborns. The clinical condition of the infant immediately after birth and the response to resuscitative measures are not
reliable prognostic factors.
Review article Swiss Med Wkly. 2011;141:w13280
Swiss Medical Weekly · PDF of the online version · www.smw.ch Page 8 of 13
ity. It is indispensable to prospectively collect data on mor-
tality and morbidity that are periodically reviewed both na-
tionally and locally. In addition, information on motor and
cognitive development of these children should be collec-
ted up to school age. It is imperative that the necessary re-
sources are made available. To be able to guarantee a high
quality of perinatal care and follow-up, these infants must
be treated and followed by adequately trained and qualified
professionals in specialised level III centres.
Available studies from Switzerland document that most
deaths in neonatal intensive care units are preceded by re-
direction of care decisions [53–55]. In the future, decisions
that lead to withholding or withdrawing of life-sustaining
therapies either in the setting of primary non-intervention
or following redirection of care should be prospectively
collected and analysed.
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Figures (large format)
Figure 1
Impact of positive risk factors on shared decision making with the parents in preterm infants with a gestational age between 23 0/7 and 23 6/7
weeks.
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Figure 2
Impact of positive or negative risk factors on shared decision making with the parents in preterm infants with a gestational age between 24 0/7
and 24 6/7 SSW.
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Figure 3
Impact of negative risk factors on shared decision making with the parents in preterm infants with a gestational age between 25 0/7 and 25 6/7
SSW.
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